BioSpace News Archive

NEOGEN Corporation (NASDAQ: NEOG) announced today that they have partnered with the Center for Aquaculture Technologies (CAT) to deliver high-quality genotyping services customized to the unique needs of aquaculture producers.

Albert Einstein Cancer Center, Albert Einstein College of Medicine, and Montefiore Health System announced that Lauren Hackett, M.P.A., has been appointed the deputy director of administration of AECC and associate vice president of cancer medicine at Montefiore Medicine.

Otolith Labs, launched at the Halcyon Incubator, announced today it has received U.S. Food and Drug Administration (FDA) BREAKTHROUGH DEVICE designation for its medical device that is designed to be prescribed by physicians for the treatment of vertigo.

Incyte (Nasdaq:INCY) today announced the outcome of a meeting of the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA), which reviewed the Biologics License Application (BLA) for retifanlimab, an intravenous PD-1 inhibitor, as a potential treatment for adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC) who have progressed on, or who are intolerant of, platinum-based chemotherapy.

Findings Published in Nature Chemical Biology Support Clinical Development of RMC-5552, the Company’s First-in-Class, Phase 1/1b Bi-steric mTORC1-Selective Inhibitor

Adverum Biotechnologies, Inc. today announced that Leone Patterson, president and chief financial officer, has resigned to pursue another opportunity.

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has filed a premarket approval (PMA) supplement with the FDA for its newly developed, long-lived, non-rechargeable sacral neuromodulation (SNM) implantable neurostimulator (INS).

AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021

IQVIA™ (NYSE: IQV) today introduced Clinical Data Analytics Suite (CDAS) , a new SaaS-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single, standardized setting for easier access and use.

OncoSec Medical Incorporated today announced that Daniel O’Connor has resigned and that Brian Leuthner , formerly Chief Operating Officer, has been appointed Interim Chief Executive Officer, effective June 25, 2021 .